The ROS1ders, Inc.
@ros1cancer
Global community of patients & caregivers improving outcomes for ROS1+ cancers through community, education and research. #ROS1cancer #LCSM
ID: 796831426427514880
http://theros1ders.org 10-11-2016 21:46:31
1,1K Tweet
1,1K Followers
185 Following
Love it when this happens. 2 independent labs publish nearly identical findings within a few weeks. Congrats to Ryohei Katayama and lab! #greatmindsthinkalike #LCSM ALK Positive The ROS1ders, Inc. insight.jci.org/articles/view/…
Happy to get the word out for #biomarker testing for ALL patients with #lungcancer and discuss the importance of clinical trials for patients. My job was made so much easier by the one and only Janet Freeman-Daily! The ROS1ders, Inc. #LCSM Chat The White Ribbon Project™
Behind the scenes from today's ROS1 Satellite Media Tour with Tejas Patil & Janet Freeman-Daily
MUST READ piece The New Yorker by Siddhartha Mukherjee on the causes of cancer, role of carcinogens, inflammation, with Charles Swanton +team, Balmain, and more. “Swanton's team had wrestled the mystery down using epidemiology, toxicology, immunology, and human genetics, and then
One of our cofounders (Janet Freeman-Daily) is a panelist for an FDA "Conversations on Cancer "! Register at surveymonkey.com/r/FTYFN3H to hear patient and investigator perspectives on some transformative oncology drug approvals from 2023 -- including one for ROS1+ cancer. #ROS1
sciencedirect.com/science/articl… Let’s try it with this link! #LCSM The ROS1ders, Inc. RosesfromaRos1der Updates on OS by Sebastian Michels on our #EUCROSS trial. Great work!
I'm thrilled to share our article "The Efficacy and Safety of Treating Acquired MET Resistance Through Combinations of Parent and MET Tyrosine Kinase Inhibitors in Patients With Metastatic Oncogene-Driven NSCLC" - now in JTO & JTO CRR! ➡️jtocrr.org/article/S2666-… 👇🏾DETAILS BELOW!
